Gresia L. Cervantes-Navarro

Jan 20, 2024 | biorxiv.org | Theodore Nelson |Claire Walter |Julianna K. Rose |Gresia L. Cervantes-Navarro

AbstractTen years ago, it was predicted that the multi-omics revolution would also revolutionize space pharmacogenomics. Current barriers related to the findable, accessible, interoperable, and reproducible use of space-flown pharmaceutical data have contributed to a lack of progress beyond application of earth-based principles.